Benzinga’s Top Upgrades (UTHR, MBT, CHRW, OMCL)

United Therapeutics Corporation UTHR was upgraded by JP Morgan from “neutral” to “overweight.” UTHR’s shares closed at $51.50 yesterday. United Therapeutics’ earnings are likely to grow by 132.19% this year. Credit Suisse upgraded Mobile TeleSystems MBT from “underperform” to “neutral.” MBT’s shares closed at $18.53 yesterday. Mobile TeleSystems’ trailing-twelve-month gross margin is 76.15%. RW Baird upgraded CH Robinson Worldwide Inc CHRW from “neutral” to “outperform.” CHRW closed at $55.03 yesterday. CH Robinson’s trailing-twelve-month ROI is 32.66%. Analysts at Auriga upgraded Omnicell Inc OMCL from “hold” to “buy.” OMCL’s shares closed at $11.84 yesterday. Omnicell’s quarterly earnings grew 149.64%. More Analyst Ratings here